| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $2.59 (Beat by $0.05) |
| EPS GAAP Actual | $2.59 (Beat by $0.05) |
| Revenue Actual | $9.758B |
| Revenue Surprise | Beat by $9758M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.7171 |
| EPS GAAP Estimate | $2.7171 |
| Revenue Estimate | $9.605913762B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 14.04182 | 16.98 | 13.7712 | 14.31209 | 4 |
| Dec 2028 | 13.5 | 17.66 | 13.21126 | 13.88932 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.46 | -2.23757 | 9.758B | -3.38% | -407.17M |
| FQ3 2025 (Sep 2025) | 2.87 | 0.32999 | 10.408B | 6.5% | 593.37M |
| FQ2 2025 (Jun 2025) | 2.46 | -0.23036 | 0B | -INF% | -10088.78M |
| FQ1 2025 (Mar 2025) | 2.24 | -0.14504 | 9.822B | 7.3% | 281.11M |
| FQ4 2024 (Dec 2024) | 1.98 | 1.98 | 10.088B | 6.42% | 10088M |
| FQ3 2024 (Sep 2024) | 2.17 | 2.17 | 9.731B | 5.33% | 9731M |
| FQ2 2024 (Jun 2024) | 2.37 | 2.37 | 9.575B | 100% | 9575M |
| FQ1 2024 (Mar 2024) | 2.24 | 2.24 | 9.105B | 2.65% | 9105M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.7171
Consensus Revenue Estimates
9.605913762B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.29236 | -- | 3.23947 | 3.35939 | 7 |
| FQ3 2027 (Sep 2027) | 3.10781 | -- | 3.06361 | 3.14995 | 4 |
| FQ2 2027 (Jun 2027) | 3.1056 | -- | 3.06143 | 3.14771 | 3 |
| FQ1 2027 (Mar 2027) | 2.77953 | -- | 2.71658 | 2.83419 | 4 |
| FQ4 2026 (Dec 2026) | 3.3155 | 86.13 | 3.3155 | 3.3155 | 8 |
| FQ3 2026 (Sep 2026) | 3.0008 | 4.36 | 3.0008 | 3.0008 | 8 |
| FQ2 2026 (Jun 2026) | 2.9552 | 16.76 | 2.9552 | 2.9552 | 8 |
| FQ1 2026 (Mar 2026) | 2.7171 | 17.56 | 2.7171 | 2.7171 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 11.9B | -- | 11.75B | 12.09B | 6 |
| FQ3 2027 (Sep 2027) | 11.12B | -- | 11B | 11.24B | 2 |
| FQ2 2027 (Jun 2027) | 11.08B | -- | 10.96B | 11.2B | 2 |
| FQ1 2027 (Mar 2027) | 10.41B | -- | 10.23B | 10.57B | 4 |
| FQ4 2026 (Dec 2026) | 9.62B | -1.44 | 9.62B | 9.62B | 10 |
| FQ3 2026 (Sep 2026) | 9.61B | -8.25 | 9.61B | 9.61B | 7 |
| FQ2 2026 (Jun 2026) | 9.61B | -- | 9.61B | 9.61B | 5 |
| FQ1 2026 (Mar 2026) | 9.61B | -2.25 | 9.61B | 9.61B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.69757 | 0.46 | -2.23757 | -486.43% |
| FQ3 2025 (Sep 2025) | 2.54001 | 2.87 | 0.32999 | 11.5% |
| FQ2 2025 (Jun 2025) | 2.69036 | 2.46 | -0.23036 | -9.36% |
| FQ1 2025 (Mar 2025) | 2.38504 | 2.24 | -0.14504 | -6.47% |
| FQ4 2024 (Dec 2024) | 1.98 | 1.98 | 100% | |
| FQ3 2024 (Sep 2024) | 2.17 | 2.17 | 100% | |
| FQ2 2024 (Jun 2024) | 2.37 | 2.37 | 100% | |
| FQ1 2024 (Mar 2024) | 2.24 | 2.24 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $10.17B | $9.76B | $-407.17M | -4.17% |
| FQ3 2025 (Sep 2025) | $9.81B | $10.41B | $593.37M | 5.7% |
| FQ2 2025 (Jun 2025) | $10.09B | $0B | $-10088.78M | -INF% |
| FQ1 2025 (Mar 2025) | $9.54B | $9.82B | $281.11M | 2.86% |
| FQ4 2024 (Dec 2024) | $0B | $10.09B | $10088M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $9.73B | $9731M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $9.58B | $9575M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $9.11B | $9105M | 100% |